In a drug discovery career spanning more than two decades, Alex Lugovskoy has seen a lot of antibodies come and go. The vast majority of them work by inhibiting a cellular function. Lugovskoy, now the ...
Behind the Scenes of Architectural Design 5The 'Diagonal Diagonal' BeamIn steel construction, when attaching an H-shaped ...
WATERTOWN, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Diagonal Therapeutics, a biotechnology company developing disease-modifying clustering antibodies that correct dysregulated signaling in severe ...
CAMBRIDGE, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Diagonal Therapeutics, a biotechnology company pioneering a new approach to discovering and developing agonist antibodies, launched today with $128 ...
The MarketWatch News Department was not involved in the creation of this content. Financing co-led by Sanofi Ventures and Janus Henderson Investors, with participation from new investors Deep Track ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results